Thanks for sharing the video.
I used couple of AI tools to extract the video transcript and generate the following highlights of Sean Hair's responses (there might be some typos).
Brain Chip Overview:
Brain Chip is a key player in the semiconductor industry, supplying intellectual property for organizations seeking to build custom chips.Specializes in providing solutions for inference outside the traditional data centre, catering to the emerging needs of edge computing.Recognizes the shift in AI workloads moving towards the edge, outside data centres, and positions itself to address this trend.Akida Platform 2.0:
Generation 2 (Akkio Platform 2.0) enhances capabilities compared to the previous generation.Introduces flexibility by supporting a range of bit sizes, including 8-bit, 4-bit, 2-bit, and 1-bit, accommodating diverse use cases.Notable features include the addition of long-range skip connections and support for models created in PyTorch.Business Model:
Brain Chip primarily operates on an intellectual property (IP) business model, providing customizable solutions for companies.Demonstrates IP functionality through reference chips (Akida), showcasing versatility and compatibility across various foundries.Edge Market Developments:
Recognizes the rapid growth and dynamism of the emerging Edge Market.Brain Chip stands out in this underserved market by offering solutions that excel in both low power consumption and high performance.Business Development and Growth:
Significant organizational growth witnessed, particularly in the sales and marketing domains.Establishment of a global presence with representatives in key regions such as Asia, Europe, North America, and Israel.Implementation of a robust ecosystem partnership program, fostering collaborations with key industry players.Partnerships and Collaborations:
Emphasizes partnerships over traditional client relationships, citing the collaboration with Arm as an example.Maintains strategic collaborations, such as the one with Mercedes, with a focus on long-term, mutually beneficial engagements.Stresses the importance of understanding and meeting partners' functional and technical requirements.Market Opportunities:
Acknowledges the varied needs of partners, particularly in terms of functionality and technical improvements.Highlights ongoing partnerships, such as those with Mercedes and Arm, as examples of collaboration towards shared goals.Places importance on thorough testing, documentation, and alignment with partners' needs to foster successful and enduring collaborations.
- Forums
- ASX - By Stock
- BRN
- 2024 BrainChip Discussion
2024 BrainChip Discussion, page-3230
-
- There are more pages in this discussion • 3,709 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BRN (ASX) to my watchlist
(20min delay)
|
|||||
Last
19.5¢ |
Change
-0.005(2.50%) |
Mkt cap ! $366.5M |
Open | High | Low | Value | Volume |
20.0¢ | 20.5¢ | 19.5¢ | $878.2K | 4.371M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
64 | 1444914 | 19.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.0¢ | 388739 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
64 | 1444914 | 0.195 |
62 | 1739410 | 0.190 |
33 | 1759832 | 0.185 |
50 | 1530443 | 0.180 |
16 | 598862 | 0.175 |
Price($) | Vol. | No. |
---|---|---|
0.200 | 388739 | 9 |
0.205 | 944687 | 16 |
0.210 | 1398298 | 25 |
0.215 | 506951 | 23 |
0.220 | 758461 | 24 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
BRN (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online